Edwin T. Parlevliet

Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice

Sander Kooijman, Yanan Wang, Edwin T. Parlevliet et al. · Diabetologia · 2015 · 135 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Exendin‐4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration

Yanan Wang, Edwin T. Parlevliet, Janine J. Geerling et al. · British Journal of Pharmacology · 2013 · 122 citations · Full text

Veterinary Medicine, Endocrinology, Pharmacology +17

GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice

Edwin T. Parlevliet, Yanan Wang, Janine J. Geerling et al. · PLoS ONE · 2012 · 90 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice

Annemieke C. Heijboer, Anita M. van den Hoek, Edwin T. Parlevliet et al. · Diabetologia · 2006 · 80 citations · Full text

Life Sciences, Endocrinology, Nutritional Sciences +12

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

J. E. de Leeuw van Weenen, Edwin T. Parlevliet, Pierre Maechler et al. · Biochemical Pharmacology · 2010 · 79 citations

Medicine, Endocrinology, Pharmacology +17